Table 4 Results for overall and sub-group analysis according to type of study and treatment
From: Community based interventions for the prevention and control of Non-Helmintic NTD
Outcomes | Estimates (95% CI) | Â | |||
|---|---|---|---|---|---|
| Â | Combined | RCTs | Pre-post studies | Preventive | Therapeutic |
Chagas | |||||
Peri-domiciliary Infestation Rate | 0.77 [0.53, 1.14] | 0.94 [0.67, 1.32] | 0.17 [0.06, 0.48] | 0.77 [0.53, 1.14] | No studies |
8 datasets, 3 studies | 4 datasets, 1 study | 4 datasets, 2 studies | 8 datasets, 3 studies | ||
Domiciliary Infestation Rate | 0.32 [0.19, 0.55] | No studies | 0.32 [0.19, 0.55] | 0.32 [0.19, 0.55] | No studies |
4 datasets, 2 studies | Â | 4 datasets, 2 studies | 4 datasets, 2 studies | ||
Chagas Serology Rate (RR) | 0.78 [0.61, 0.98] | No studies | 0.78 [0.61, 0.98] | 0.78 [0.61, 0.98] | No studies |
4 datasets, 2 studies | 4 datasets, 2 studies | 4 datasets, 2 studies | |||
Dengue | |||||
House Index | 0.84 [0.81, 0.88] | No studies | 0.84 [0.81, 0.88] | 0.84 [0.81, 0.88] | No studies |
9 datasets, 9 studies | 9 datasets, 9 studies | 9 datasets, 9 studies | |||
Ovitrap Index | 0.77 [0.64, 0.92] | No studies | 0.77 [0.64, 0.92] | 0.77 [0.64, 0.92] | No studies |
5 datasets, 3 studies | 5 datasets, 3 studies | 5 datasets, 3 studies | |||
Mean Bretreau Index (SMD) | −0.04 [−0.28, 0.19] | −0.04 [−0.28, 0.19] | No studies | −0.04 [−0.28, 0.19] | No studies |
5 datasets, 2 studies | 5 datasets, 2 studies | 5 datasets, 2 studies | |||
Dengue Positive Serostatus | 0.31 [0.18, 0.53] | 0.33 [0.18, 0.60] | 0.14 [0.01, 1.62] | 0.31 [0.18, 0.53] | No studies |
4 datasets, 4 studies | 2 datasets, 2 studies | 2 datasets, 2 studies | 4 datasets, 4 studies | ||
Trachoma | |||||
Active Trachoma All Age Groups | 0.24 [0.21, 0.26] | 0.72 [0.59, 0.88] | 0.15 [0.14, 0.17] | 0.72 [0.59, 0.88] | 0.15 [0.14, 0.17] |
6 datasets, 3 studies | 2 datasets, 1 study | 4 datasets, 2 studies | 2 datasets, 1 study | 4 datasets, 2 studies | |
Active Trachoma in Children | 0.67 [0.64, 0.69] | 0.86 [0.83, 0.90] | 0.38 [0.36, 0.40] | 0.77 [0.74, 0.79] | 0.32 [0.29, 0.35] |
20 datasets, 14 studies | 6 datasets, 4 studies | 14 datasets, 9 studies | 13 datasets, 8 studies | 7 datasets, 6 studies | |
Chlamydia Trachomatic infection- All Age Groups | 0.29 [0.27, 0.32] | 0.28 [0.25, 0.31] | 0.32 [0.27, 0.37] | 0.28 [0.25, 0.31] | 0.36 [0.29, 0.46] |
10 datasets, 6 studies | 5 datasets, 3 studies | 5 datasets, 3 studies | 7 datasets from 5 studies | 3 datasets, 1 studies | |
Chlamydia Trachomatic infection in Children | 0.21 [0.18, 0.24] | 0.15 [0.13, 0.19] | 0.42 [0.31, 0.55] | 0.21 [0.18, 0.24] | No studies |
9 datasets, 7 studies | 6 datasets, 4 studies | 3 datasets, 3 studies | 9 datasets, 7 studies | ||
Leishmaniasis | |||||
Incidence Cutaneous Leishmaniasis | 0.42 [0.36, 0.49] | 0.40 [0.32, 0.51] | 0.43 [0.35, 0.53] | 0.42 [0.36, 0.49] | No studies |
9 datasets, 5 studies | 5 datasets, 3 studies | 4 datasets, 2 studies | 9 datasets, 5 studies | ||
Incidence of Visceral Leishmaniasis | 0.93 [0.83, 1.04] | 0.97 [0.84, 1.12] | 0.87 [0.73, 1.04] | 0.93 [0.83, 1.04] | No studies |
4 datasets, 4 studies | 2 datasets, 2 studies | 2 datasets, 2 studies | 4 datasets, 4 studies | ||
Cure Rate for Cutaneous Leishmaniasis (RR) | 0.92 [0.88, 0.96] | No studies | 0.92 [0.88, 0.96] | No studies | 0.92 [0.88, 0.96] |
2 datasets, 2 studies | 2 datasets, 2 studies | 2 datasets, 2 studies | |||
Leprosy | |||||
Leprosy Incidence | 0.32 [0.30, 0.34] | 0.67 [0.49, 0.92] | 0.31 [0.29, 0.33] | 0.32 [0.30, 0.34] | No studies |
8 datasets, 5 studies | 1 datasets, 1 studies | 7 datasets, 4 studies | 8 datasets, 5 studies | ||
Leprosy detection rate | 1.11 [1.02, 1.21] | No studies | 1.11 [1.02, 1.21] | 1.11 [1.02, 1.21] | No studies |
| Â | 2 datasets, 2 studies | Â | 2 datasets, 2 studies | 2 datasets, 2 studies | Â |